de Bock GH - Search Results

1

Distinct Biomarker Profiles and Clinical Characteristics in T1-T2 Glottic and Supraglottic Carcinomas.

Wachters JE, Kop E, Slagter-Menkema L, Mastik M, van der Wal JE, van der Vegt B, de Bock GH, van der Laan BFAM, Schuuring E. Wachters JE, et al. Among authors: de bock gh. Laryngoscope. 2020 Dec;130(12):2825-2832. doi: 10.1002/lary.28532. Epub 2020 Feb 17. Laryngoscope. 2020. PMID: 32065407 Free PMC article.

2

EGFR expression is associated with groin node metastases in vulvar cancer, but does not improve their prediction.

Oonk MH, de Bock GH, van der Veen DJ, Ten Hoor KA, de Hullu JA, Hollema H, van der Zee AG. Oonk MH, et al. Among authors: de bock gh, de hullu ja. Gynecol Oncol. 2007 Jan;104(1):109-13. doi: 10.1016/j.ygyno.2006.07.035. Epub 2006 Sep 11. Gynecol Oncol. 2007. PMID: 16963112 Free article.

3

p53 overexpression is a predictor of local recurrence after treatment for both in situ and invasive ductal carcinoma of the breast.

de Roos MA, de Bock GH, de Vries J, van der Vegt B, Wesseling J. de Roos MA, et al. Among authors: de vries j, de bock gh. J Surg Res. 2007 Jun 1;140(1):109-14. doi: 10.1016/j.jss.2006.10.045. Epub 2007 Feb 7. J Surg Res. 2007. PMID: 17291532 Free article.

4

Pathological and biological differences between screen-detected and interval ductal carcinoma in situ of the breast.

de Roos MA, van der Vegt B, de Vries J, Wesseling J, de Bock GH. de Roos MA, et al. Among authors: de vries j, de bock gh. Ann Surg Oncol. 2007 Jul;14(7):2097-104. doi: 10.1245/s10434-007-9395-7. Epub 2007 Apr 24. Ann Surg Oncol. 2007. PMID: 17453296 Free PMC article.

5

The expression pattern of MUC1 (EMA) is related to tumour characteristics and clinical outcome of invasive ductal breast carcinoma.

van der Vegt B, de Roos MA, Peterse JL, Patriarca C, Hilkens J, de Bock GH, Wesseling J. van der Vegt B, et al. Among authors: de roos ma, de bock gh. Histopathology. 2007 Sep;51(3):322-35. doi: 10.1111/j.1365-2559.2007.02757.x. Epub 2007 Jul 23. Histopathology. 2007. PMID: 17645748 Free article.

6

The expression pattern of MUC1 (EMA) is related to tumour characteristics and clinical outcome in 'pure' ductal carcinoma in situ of the breast.

de Roos MA, van der Vegt B, Peterse JL, Patriarca C, de Vries J, de Bock GH, Wesseling J. de Roos MA, et al. Among authors: de vries j, de bock gh. Histopathology. 2007 Aug;51(2):227-38. doi: 10.1111/j.1365-2559.2007.02754.x. Histopathology. 2007. PMID: 17650217

7

Amplicon mapping and expression profiling identify the Fas-associated death domain gene as a new driver in the 11q13.3 amplicon in laryngeal/pharyngeal cancer.

Gibcus JH, Menkema L, Mastik MF, Hermsen MA, de Bock GH, van Velthuysen ML, Takes RP, Kok K, Alvarez Marcos CA, van der Laan BF, van den Brekel MW, Langendijk JA, Kluin PM, van der Wal JE, Schuuring E. Gibcus JH, et al. Among authors: de bock gh. Clin Cancer Res. 2007 Nov 1;13(21):6257-66. doi: 10.1158/1078-0432.CCR-07-1247. Clin Cancer Res. 2007. PMID: 17975136

8

Cortactin expression predicts poor survival in laryngeal carcinoma.

Gibcus JH, Mastik MF, Menkema L, de Bock GH, Kluin PM, Schuuring E, van der Wal JE. Gibcus JH, et al. Among authors: de bock gh. Br J Cancer. 2008 Mar 11;98(5):950-5. doi: 10.1038/sj.bjc.6604246. Epub 2008 Feb 12. Br J Cancer. 2008. PMID: 18268491 Free PMC article.

9

Overexpression of intrinsic hypoxia markers HIF1alpha and CA-IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy.

Schrijvers ML, van der Laan BF, de Bock GH, Pattje WJ, Mastik MF, Menkema L, Langendijk JA, Kluin PM, Schuuring E, van der Wal JE. Schrijvers ML, et al. Among authors: de bock gh. Int J Radiat Oncol Biol Phys. 2008 Sep 1;72(1):161-9. doi: 10.1016/j.ijrobp.2008.05.025. Int J Radiat Oncol Biol Phys. 2008. PMID: 18722267

10

Microarray methods to identify factors determining breast cancer progression: potentials, limitations, and challenges.

van der Vegt B, de Bock GH, Hollema H, Wesseling J. van der Vegt B, et al. Among authors: de bock gh. Crit Rev Oncol Hematol. 2009 Apr;70(1):1-11. doi: 10.1016/j.critrevonc.2008.09.001. Epub 2008 Oct 9. Crit Rev Oncol Hematol. 2009. PMID: 18848465 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

567 results

Search Page